Butantan Institute
Clinical trials sponsored by Butantan Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Dengue vaccine trial aims to protect seniors Results expected Mar 2027 (estimated)
- One shot, two protections? new trial combines dengue and chikungunya vaccines Results expected Jul 2027 (estimated)
- New H5N8 bird flu vaccine enters human trials Results expected Aug 2027 (estimated)
-
Could a second dose of dengue vaccine boost protection for kids?
Vaccine Not yet recruitingThis study tests whether a two-dose regimen of the Butantan-DV dengue vaccine, given nine months apart, produces a stronger immune response than a single dose in children and adolescents aged 2 to 17 who have never had dengue. The trial also checks that the vaccine made at a new …
Phase 3 • Sponsor: Butantan Institute • Aim: Vaccine
Last updated Jul 22, 2026 00:00 UTC
-
One shot, two protections? new trial combines dengue and chikungunya vaccines
Vaccine Not yet recruitingThis Phase 3 trial will test whether giving the dengue and chikungunya vaccines at the same time is as safe and effective as giving them separately. The study involves 900 healthy adults aged 18 to 59 who have never been exposed to either virus. Researchers will measure immune re…
Phase 3 • Sponsor: Butantan Institute • Aim: Vaccine
Last updated Jul 18, 2026 00:00 UTC